AJMC® in the Press, December 15, 2023

A study entitled, “Treatment Modification After Initiating Second-Line Medication for Type 2 Diabetes,” to be published in the December 2023 issue of The American Journal of Managed Care^® (AJMC^®), was referenced in articles from US News & World Report, Medpage Today, Medical News Today, Healio, HealthDay, and Medical Economics^®. The study found that approximately 40% of patients with type 2 diabetes discontinued their second-line therapies within a year.

An article from Medriva referenced an article published on AJMC.com, the website of AJMC. The article, “Health Insurance Markets Remain Highly Concentrated in the Majority of US,” covered a report from the American Medical Association that found the market for health insurance, both commercial and Medicare Advantage, became more concentrated from 2014 to 2022.